ticlopidine has been researched along with Arteriosclerosis Obliterans in 8 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nifedipine doesn't produce any effect on platelet aggregation." | 2.67 | [The effects of ticlopidine and nifedipine on platelet aggregation in patients with obliterating arteriopathy of the lower limbs]. ( Fernández-Sanz, S; Gago Angelino, J; Hevia Alonso, A; López-Valpuesta, FJ; Serrano Molina, JS, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nikuhinikov, PI | 1 |
| Bytsay, AN | 1 |
| Lysak, LI | 1 |
| Yatsenko, AI | 1 |
| Abramenko, AV | 1 |
| Guo, B | 1 |
| Tan, Q | 1 |
| Guo, D | 1 |
| Shi, Z | 1 |
| Zhang, C | 1 |
| Guo, W | 1 |
| Tan, JY | 1 |
| Shi, WH | 1 |
| He, J | 1 |
| Zhu, L | 1 |
| Wang, TP | 1 |
| Yu, B | 1 |
| Koshkin, VM | 1 |
| Stoĭko, IuM | 1 |
| Leo, W | 1 |
| Westrych, R | 1 |
| Bissinger, A | 1 |
| Okraszewski, J | 1 |
| Baj, Z | 1 |
| Hevia Alonso, A | 1 |
| Gago Angelino, J | 1 |
| López-Valpuesta, FJ | 1 |
| Serrano Molina, JS | 1 |
| Fernández-Sanz, S | 1 |
| Strano, A | 2 |
| Davì, G | 2 |
| Cannizzaro, S | 1 |
| Giubilato, A | 1 |
| Pinto, A | 1 |
| Francavilla, G | 1 |
| Paterna, S | 1 |
| Campisi, D | 1 |
1 review available for ticlopidine and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[Platelet function inhibitors in peripheral arteriopathies].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; A | 1986 |
4 trials available for ticlopidine and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[A clinical trial of using antiplatelet therapy to prevent restenosis following peripheral artery angioplasty and stenting].
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Arteriosclerosis Obliterans; Aspirin; Cathe | 2008 |
[Effect of the acetylosalicyd acid (ASA) and ticlopidine therapy on clinical condition and parameters of blood platelets in patients with peripheral arterial occlusive disease (PAOD)].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Aspirin; Blood Platelets; Exercise Test; Female; Humans; M | 2007 |
[The effects of ticlopidine and nifedipine on platelet aggregation in patients with obliterating arteriopathy of the lower limbs].
Topics: Arteriosclerosis Obliterans; Clinical Trials as Topic; Female; Humans; Leg; Male; Middle Aged; Nifed | 1992 |
[Platelet function inhibitors in peripheral arteriopathies].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; A | 1986 |
4 other studies available for ticlopidine and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[[Impact of plestazol preparation on hyperplasia of inter vascular layer in the patients, suffering obliterating atherosclerosis of the lower extremities arteries after reconstructive operations].]
Topics: Aged; Aged, 80 and over; Arteriosclerosis Obliterans; Biomarkers; Case-Control Studies; Cilostazol; | 2016 |
Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease.
Topics: Aged; Alleles; Angiography, Digital Subtraction; Ankle Brachial Index; Arteriosclerosis Obliterans; | 2014 |
[Conservative treatment of lower limb chronic obliterative atherosclerosis: strategy and tactics].
Topics: Arteriosclerosis Obliterans; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Fibrinolyt | 2005 |
Inhibition of platelet function by ticlopidine in arteriosclerosis obliterans of the lower limbs.
Topics: Aged; Arteriosclerosis Obliterans; beta-Thromboglobulin; Blood Platelets; Double-Blind Method; Drug | 1985 |